One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Ambulatory Cardiac Monitoring Market

[ 英語タイトル ] Ambulatory Cardiac Monitoring Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0083905
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- GE Healthcare
- iRhythm Technologies Inc
- Biotronik
- Schiller
- Medicomp Inc.
- Biotelemetry
- Applied Cardiac System
- MicroPort

[Report Description]

Ambulatory Cardiac Monitoring market is driven by an increase in the prevalence of heart diseases, growing ageing population who are very susceptible to the coronary heart diseases and technological developments in cardiac monitoring devices that minimizing the chances of infection and improved efficiency of devices.

According to the WHO reports, it is estimated that cardiovascular diseases take the lives of 17.9 million people every year, 31% of all global deaths. However, rising incidences of infection, high cost associated with the monitoring and stringent regulatory procedures may act as restraints for the growth of ambulatory cardiac monitoring market over the forecast period.

Key Market Trends

ECG Monitors Projected to Have Notable Growth Rate

- As there is an increase in the incidence of cardiovascular diseases (CVD), long-term ECG monitoring is necessary. Usually, this procedure is possible in hospitals. However, with the introduction of wireless ECG, the doctors can monitor and diagnose the patient remotely and on time. There are two different types of ECG monitors available in the market namely the ECG Monitors and diagnostic ECG systems.
- The wireless ECG monitors were developed by many several market players. These devices can be used for the continuous monitoring of patients suffering from CVD and for the detection of problems when they are usually easier to treat while avoiding life-threatening and expensive emergency admissions.
- Frequent product launches in the respective segment are one of the major factors driving the market. For instance, in September 2018, Icentia Inc., a medical device company offering ambulatory medical testing solutions, today announced it has received Class II Medical Device CE Mark approval for its CardioSTAT continuous ECG monitoring system.

Asia Pacific is expected to grow with a significant CAGR over the forecast period

The Asia Pacific expected to witness significant growth due to the increasing prevalence of cardiovascular disease, growing technological advancements, rapid growth in the economy and favourable initiatives by the government. Additionally, the launch of several health awareness programs, the introduction of several new products, and new techniques in minimally invasive surgery are expected to reinforce growth prospects over the forecast period in the Asia Pacific region. For instance, In 2018, Qardio, Inc., received the approval from Australia’s Therapeutic Goods Administration (TGA) for QardioCore, its revolutionary ECG monitor.

Competitive Landscape

Ambulatory Cardiac monitoring market is highly fragmented and focused owing to the presence of a large number of market players. The companies in ambulatory cardiac monitoring market are focusing on various growth strategies such to enhance their market presence such as M&A, partnerships, collaborations, geographical expansions, new product launches.

For instance, in May 2018, GE Healthcare and Preventice Solutions entered into a collaboration to provide customers with an extension of the hospital heart station and to expand GE Healthcare ECG services into the home, creating a more holistic solution for monitoring ambulatory ECG patients.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Incidences of Cardiovascular Diseases
4.2.2 Advances in Ambulatory Cardiac Monitoring Devices
4.3 Market Restraints
4.3.1 Risk of Infection Due to Implantable Monitoring Devices
4.3.2 Price Sensitive Market
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Device Type
5.1.1 ECG Monitors
5.1.2 Event Recorders
5.1.3 Implantable Cardiac Loop Recorders
5.1.4 Mobile Cardiac Telemetry
5.1.5 Others
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.2.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Medtronic plc
6.1.2 Abbott Laboratories
6.1.3 Boston Scientific Corporation
6.1.4 GE Healthcare
6.1.5 iRhythm Technologies Inc
6.1.6 Biotronik
6.1.7 Schiller
6.1.8 Medicomp Inc.
6.1.9 Biotelemetry
6.1.10 Applied Cardiac System
6.1.11 MicroPort




Recommended reports